Combination of transcriptomic and proteomic approaches helps unravel the mechanisms of luteolin in inducing liver cancer cell death via targeting AKT1 and SRC
IntroductionLuteolin, a natural compound commonly used in traditional Chinese medicine, shows clinical potential as an anti-liver cancer agent. The mechanisms underlying the anti-liver cancer effect of luteolin are limited versus those reported for other cancers. Accordingly, this study was conducte...
Saved in:
Main Authors: | Junxia Ma (Author), Jinggang Mo (Author), Yifu Feng (Author), Liezhi Wang (Author), Hao Jiang (Author), Junmin Li (Author), Chong Jin (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The mechanism of flavonoids from Cyclocarya paliurus on inhibiting liver cancer based on in vitro experiments and network pharmacology
by: Jinggang Mo, et al.
Published: (2023) -
ATP-Binding Pocket-Targeted Suppression of Src and Syk by Luteolin Contributes to Its Anti-Inflammatory Action
by: Jeong-Oog Lee, et al.
Published: (2015) -
Transcriptome, proteomics and metabonomics in dermatology
by: Qian LI, et al.
Published: (2022) -
Dietary Flavonoids Luteolin and Quercetin Inhibit Migration and Invasion of Squamous Carcinoma through Reduction of Src/Stat3/S100A7 Signaling
by: Jhen-Jia Fan, et al.
Published: (2019) -
Combined Transcriptomic and Proteomic Profiling to Unravel Osimertinib, CARP-1 Functional Mimetic (CFM 4.17) Formulation and Telmisartan Combo Treatment in NSCLC Tumor Xenografts
by: Ramesh Nimma, et al.
Published: (2022)